Priority Date: 10.05.12 (AU 20120901918)

METHODS OF TREATING CANCER USING ANGIOGENIN OR AN ANGIOGENIN AGONIST

  • Application ID: EP13787726
  • Status: GRANT OF PATENT INTENDED

Attorney

operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Mewburn Ellis LLP is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 10.05.2012 - Priority Date (AU 20120901918)
  • 14.11.2013 - Publication A1 (WO2013166555)
  • 18.03.2015 - Publication A1 (EP2846820)

IPC Classification